Discovery of Novel Antimalarial Compounds Enabled by QSAR-Based Virtual Screening

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Chemical Information and Modeling

• Publication date

  2013-02-25

• Fields of study

  Biology, Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1021/ci300421nPMID 23252936PMCID PMC3644566
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• LIBSVM: A library for support vector machines

  2011cited by this paper
• Chemical Genomic Profiling for Antimalarial Therapies, Response Signatures, and Molecular Targets

  2011cited by this paper
• Thousands of chemical starting points for antimalarial lead identification

  2010cited by this paper
• Chemical genetics of Plasmodium falciparum

  2010cited by this paper
• Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research

  2010cited by this paper
• Evolving molecules using multi-objective optimization: applying to ADME/Tox.

  2010cited by this paper
• Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

  2010cited by this paper
• Precompetitive preclinical ADME/Tox data: set it free on the web to facilitate computational model building and assist drug development.

  2010cited by this paper
• New medicines to improve control and contribute to the eradication of malaria

  2009cited by this paper
• Chemoinformatics approaches to virtual screening

  2008cited by this paper
• What do we know and when do we know it?

  2008cited by this paper
• ISIDA - Platform for Virtual Screening Based on Fragment and Pharmacophoric Descriptors

  2008cited by this paper
• A study on antimalarial artemisinin derivatives using MEP maps and multivariate QSAR

  2008cited by this paper
• Combinatorial QSAR Modeling of Chemical Toxicants Tested against Tetrahymena pyriformis

  2008cited by this paper
• QSAR Modeling of the Blood–Brain Barrier Permeability for Diverse Organic Compounds

  2008cited by this paper
• Computational modeling tools for the design of potent antimalarial bisbenzamidines: overcoming the antimalarial potential of pentamidine.

  2007cited by this paper
• Predictive QSAR modeling workflow, model applicability domains, and virtual screening.

  2007cited by this paper
• A Novel Automated Lazy Learning QSAR (ALL-QSAR) Approach: Method Development, Applications, and Virtual Screening of Chemical Databases Using Validated ALL-QSAR Models

  2006cited by this paper
• A clinical drug library screen identifies astemizole as an antimalarial agent

  2006cited by this paper
• 3D-QSAR analysis of antimalarial farnesyltransferase inhibitors based on a 2,5-diaminobenzophenone scaffold.

  2006cited by this paper
• Searching for New Antimalarial Therapeutics amongst Known Drugs

  2006cited by this paper
• Combinatorial QSAR Modeling of P-Glycoprotein Substrates

  2006cited by this paper
• Identification of new antimalarial drugs by linear discriminant analysis and topological virtual screening.

  2006cited by this paper
• Antimalarial activity: a QSAR modeling using CODESSA PRO software.

  2006cited by this paper
• Non-stochastic quadratic fingerprints and LDA-based QSAR models in hit and lead generation through virtual screening: theoretical and experimental assessment of a promising method for the discovery of new antimalarial compounds.

  2006cited by this paper
• Ligand-Based Virtual Screening and in Silico Design of New Antimalarial Compounds Using Nonstochastic and Stochastic Total and Atom-Type Quadratic Maps

  2005cited by this paper
• ZINC - A Free Database of Commercially Available Compounds for Virtual Screening

  2005cited by this paper
• Application of validated QSAR models of D1 dopaminergic antagonists for database mining.

  2005cited by this paper
• Substructural fragments: an universal language to encode reactions, molecular and supramolecular structures

  2005cited by this paper
• Combinatorial QSAR of Ambergris Fragrance Compounds

  2004cited by this paper
• 3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA.

  2004cited by this paper
• Antimalarial drug discovery: old and new approaches

  2003cited by this paper
• The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models

  2003cited by this paper
• Rational selection of training and test sets for the development of validated QSAR models

  2003cited by this paper
• Quantitative Structure−Activity Relationship Analysis of Functionalized Amino Acid Anticonvulsant Agents Using k Nearest Neighbor and Simulated Annealing PLS Methods

  2002cited by this paper
• Antitumor agents. 213. Modeling of epipodophyllotoxin derivatives using variable selection k nearest neighbor QSAR method.

  2002cited by this paper
• Handbook of Molecular Descriptors

  2002cited by this paper
• QSAR Studies on Antimalarial Substituted Phenyl Analogues and Their Nω-Oxides

  2002cited by this paper
• Beware of q2!

  2002cited by this paper
• QSAR studies on antimalarial substituted phenyl analogues and their N(omega)-oxides.

  2002cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• Novel Variable Selection Quantitative Structure-Property Relationship Approach Based on the k-Nearest-Neighbor Principle

  2000cited by this paper
• A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.

  1999cited by this paper
• Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices.

  1998cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

  1997cited by this paper
• Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum.

  1993cited by this paper
• Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase.

  1991cited by this paper

• Exploring QSAR, molecular docking, molecular dynamics and pharmacokinetics for 3,4-Dihydro-2H,6H-pyrimido[1,2-c][1,3]benzothiazin-6-imine derivatives targeting Plasmodium falciparum dihydroorotate dehydrogenase

  2025cites this paper
• On the application of artificial intelligence in virtual screening

  2025cites this paper
• Design and discovery of POLQ helicase domain inhibitors by virtual screening and machine learning

  2025cites this paper
• Improved Machine Learning Predictions of EC50s Using Uncertainty Estimation from Dose–Response Data

  2025cites this paper
• Virtual screening: hope, hype, and the fine line in between

  2025cites this paper
• Structure-based screening and in vitro validation of potentially druggable molecules against Vibrio parahaemolyticus thermostable direct hemolysin (TDH) protein.

  2025cites this paper
• Machine Learning Modeling for ABC Transporter Efflux and Inhibition: Data Curation, Model Development, and New Compound Interaction Predictions

  2025cites this paper
• Kinase Drug Discovery: An Artificial Intelligence Revolution

  2025cites this paper
• Near-Term Quantum Classification Algorithms Applied to Antimalarial Drug Discovery

  2024cites this paper
• Molecular Generation, QSAR, and Molecular Dynamic Simulation Studies for Virtual Screening of DNA Polymerase Theta Inhibitors.

  2024cites this paper
• Hybrid non-animal modeling: A mechanistic approach to predict chemical hepatotoxicity.

  2024cites this paper
• Current Approaches and Strategies Applied in First‐in‐class Drug Discovery

  2024cites this paper
• QSPRmodeler - An open source application for molecular predictive analytics

  2024cites this paper
• Predicting Chemical Immunotoxicity through Data-Driven QSAR Modeling of Aryl Hydrocarbon Receptor Agonism and Related Toxicity Mechanisms

  2024cites this paper
• Data-Driven Quantitative Structure–Activity Relationship Modeling for Human Carcinogenicity by Chronic Oral Exposure

  2023cites this paper
• QSAR-based virtual screening of traditional Chinese medicine for the identification of mitotic kinesin Eg5 inhibitors

  2023cites this paper
• Identification of a Family of Glycoside Derivatives Biologically Active against Acinetobacter baumannii and Other MDR Bacteria Using a QSPR Model

  2023cites this paper
• Lo-Hi: Practical ML Drug Discovery Benchmark

  2023cites this paper
• Optimisation-based modelling for explainable lead discovery in malaria

  2023cites this paper
• ADis-QSAR: a machine learning model based on biological activity differences of compounds

  2023cites this paper
• Batched Bayesian Optimization for Drug Design in Noisy Environments

  2022cites this paper
• Drug Discovery by Automated Adaptation of Chemical Structure and Identity.

  2022cites this paper
• Systematic review on the application of machine learning to quantitative structure–activity relationship modeling against Plasmodium falciparum

  2022cites this paper
• Artificial intelligence in drug discovery: Current applications and future directions

  2022cites this paper
• Artemisinin Based Nanomedicine for Therapeutic Applications: Recent Advances and Challenges

  2022cites this paper
• Isometric Stratified Ensembles: A Partial and Incremental Adaptive Applicability Domain and Consensus-Based Classification Strategy for Highly Imbalanced Data Sets with Application to Colloidal Aggregation

  2022cites this paper
• An attention mechanism-based LSTM network for cancer kinase activity prediction

  2022cites this paper
• Predictive Global Models of Cruzain Inhibitors with Large Chemical Coverage

  2021cites this paper
• Artificial Intelligence in Medicine

  2021cites this paper
• Application of Network Pharmacology Based on Artificial Intelligence Algorithms in Drug Development

  2021cites this paper
• A Novel Automated Framework for QSAR Modeling of Highly Imbalanced Leishmania High-Throughput Screening Data

  2021cites this paper
• In Silico Approach in Drug Design and Drug Discovery: An Update

  2021cites this paper
• QSAR-Based Virtual Screening of Natural Products Database for Identification of Potent Antimalarial Hits

  2021cites this paper
• Modern Tools and Techniques in Computer-Aided Drug Design

  2021cites this paper
• Drug design of new 5-HT6R antagonists aided by artificial neural networks.

  2021cites this paper
• A Comparison between Enrichment Optimization Algorithm (EOA)-Based and Docking-Based Virtual Screening

  2021cites this paper
• Enhancing preclinical drug discovery with artificial intelligence.

  2021cites this paper
• Computational Modeling of Nonlinear Phenomena Using Machine Learning

  2020cites this paper
• Natural Antimicrobial Agents

  2020cites this paper
• Big Data and Artificial Intelligence Modeling for Drug Discovery.

  2020cites this paper
• Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling.

  2020cites this paper
• Predictive Modeling of Estrogen Receptor Agonism, Antagonism, and Binding Activities Using Machine and Deep Learning Approaches

  2020cites this paper
• Design and tests of prospective property predictions for novel antimalarial 2-aminopropylaminoquinolones

  2020cites this paper
• Predictive modeling of angiotensin I-converting enzyme (ACE) inhibitory peptides using various machine learning approaches.

  2020cites this paper
• Analysis of Chemical Spaces: Implications for Drug Repurposing

  2019cites this paper
• Ensemble-based modeling of chemical compounds with antimalarial activity.

  2019cites this paper
• In silico profiling nanoparticles: predictive nanomodeling using universal nanodescriptors and various machine learning approaches.

  2019cites this paper
• SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti-Trypanosoma brucei Agent.

  2019cites this paper
• 4D- quantitative structure–activity relationship modeling: making a comeback

  2019cites this paper
• Discussion on Regression Methods Based on Ensemble Learning and Applicability Domains of Linear Submodels

  2018cites this paper
• Antimalarial Terpenic Compounds Isolated from Plants Used in Traditional Medicine (2010–July 2016)

  2018cites this paper
• AntiMalarial Mode of Action (AMMA) Database: Data Selection, Verification and Chemical Space Analysis

  2018cites this paper
• Identification of new potential HIV-1 reverse transcriptase inhibitors by QSAR modeling and structure-based virtual screening

  2018cites this paper
• Targeting thioredoxin glutathione reductase as a potential antischistosomal drug target.

  2018cites this paper
• QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery

  2018cites this paper
• Development and Testing of Druglike Screening Libraries

  2018cites this paper
• In Silico Chemogenomics Drug Repositioning Strategies for Neglected Tropical Diseases.

  2018cites this paper
• Accessible Machine Learning Approaches for Toxicology

  2018cites this paper
• From flamingo dance to (desirable) drug discovery: a nature-inspired approach.

  2017cites this paper
• Highly selective atomic chiral index and its application to automatic assignment of chiral centers in chiral compounds

  2017cites this paper
• Quantitative Structure-Epigenetic Activity Relationships

  2017cites this paper
• Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease.

  2017cites this paper
• Advanced In Silico Approaches for Drug Discovery: Mining Information from Multiple Biological and Chemical Data Through mtk- QSBER and pt-QSPR Strategies.

  2017cites this paper
• Documenting and harnessing the biological potential of molecules in Distributed Drug Discovery (D3) virtual catalogs

  2017cites this paper
• Ligand-Based Virtual Screening Using Tailored Ensembles: A Prioritization Tool for Dual A2AAdenosine Receptor Antagonists / Monoamine Oxidase B Inhibitors.

  2016cites this paper
• Discovery of New Anti-Schistosomal Hits by Integration of QSAR-Based Virtual Screening and High Content Screening.

  2016cites this paper
• Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies

  2016cites this paper
• In Silico Studies Most Employed in the Discovery of New Antimicrobial Agents.

  2016cites this paper
• Identifying Biological Pathway Interrupting Toxins Using Multi-Tree Ensembles

  2016cites this paper
• Numeric promoter description - A comparative view on concepts and general application.

  2016cites this paper
• Inference of binding affinity from neuronal receptors in humans

  2016cites this paper
• Bagging of neural networks for analysis of nuclear receptor biological activity

  2016cites this paper
• INFERENCE OF BINDING AFFINITY FROM NEURONAL RECEPTORS IN HUMANS

  2016cites this paper
• The Next Era: Deep Learning in Pharmaceutical Research

  2016cites this paper
• Neural stem/progenitor cell 3-D differentiation for repair of central nervous system injuries

  2015cites this paper
• Quantitative structure–activity relationship: promising advances in drug discovery platforms

  2015cites this paper
• Harmonization of QSAR Best Practices and Molecular Docking Provides an Efficient Virtual Screening Tool for Discovering New G-Quadruplex Ligands

  2015cites this paper
• Discovery of anti-malarial agents through application of in silico studies.

  2015cites this paper
• The current status of antimalarial drug research with special reference to application of QSAR models.

  2015cites this paper
• Recent progress in the identification and development of anti-malarial agents using virtual screening based approaches.

  2015cites this paper
• Natural Products as Leads in Schistosome Drug Discovery

  2015cites this paper
• Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets

  2015cites this paper
• New horizons in antimalarial drug discovery in the last decade by chemoinformatic approaches.

  2015cites this paper
• A Study of Applications of Machine Learning Based Classification Methods for Virtual Screening of Lead Molecules.

  2015cites this paper
• Virtual screening tailored ensembles of QSAR models for the discovery of dual A2A Adenosine Receptor Antagonists / Monoamine Oxidase B Inhibitors

  2015cites this paper
• Machine‐learning scoring functions to improve structure‐based binding affinity prediction and virtual screening

  2015cites this paper
• Medicinal Chemistry Approaches to Neglected Diseases Drug Discovery

  2014cites this paper
• Are Bigger Data Sets Better for Machine Learning? Fusing Single-Point and Dual-Event Dose Response Data for Mycobacterium tuberculosis

  2014cites this paper
• Short communication: cheminformatics analysis to identify predictors of antiviral drug penetration into the female genital tract.

  2014cites this paper
• Toward the computer-aided discovery of FabH inhibitors. Do predictive QSAR models ensure high quality virtual screening performance?

  2014cites this paper
• Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde?

  2014cites this paper
• Virtual screening strategies in medicinal chemistry: the state of the art and current challenges.

  2014cites this paper
• Confirmation of predicted activity for factor XIa inhibitors from a virtual screening approach

  2014cites this paper
• Bayesian models for screening and TB Mobile for target inference with Mycobacterium tuberculosis.

  2014cites this paper
• Computational Models for Neglected Diseases: Gaps and Opportunities

  2014cites this paper
• QSAR modeling: where have you been? Where are you going to?

  2014cites this paper
• QSAR Modeling of Imbalanced High-Throughput Screening Data in PubChem

  2014cites this paper
• Novel anti-Plasmodial hits identified by virtual screening of the ZINC database

  2013cites this paper
• Structural features of falcipain-3 inhibitors: an in silico study.

  2013cites this paper
• Critical Evaluation of Human Oral Bioavailability for Pharmaceutical Drugs by Using Various Cheminformatics Approaches

  2013cites this paper